Surgery Partners (SGRY) and Bain Capital Conclude Discussions

Go back to Surgery Partners (SGRY) and Bain Capital Conclude Discussions

Surgery Partners (SGRY) guidance reaffirmation 'positive' despite no Bain deal - Mizuho

June 17, 2025 3:22 PM UTC

Mizuho analyst Ann Hynes reiterated an Outperform rating and a $28.00 price target on Surgery Partners (NASDAQ: SGRY) amid today's sell-off, following the company's announcement that it has concluded its discussions with Bain Capital regarding a potential acquisition. The company's independent committee determined that its long-term potential as an independent, publicly-traded company... More